Predictors of non-referral of patients with cystic fibrosis for lung transplant evaluation in the United States
- PMID: 26704622
- PMCID: PMC4828327
- DOI: 10.1016/j.jcf.2015.11.005
Predictors of non-referral of patients with cystic fibrosis for lung transplant evaluation in the United States
Abstract
Background: Lung transplantation is an intervention that improves survival for adult patients with cystic fibrosis (CF). Some patients with CF are never referred for lung transplant evaluation despite meeting physiologic criteria for referral.
Methods: We performed a retrospective analysis of adult patients (≥18years of age) in the Cystic Fibrosis Foundation Patient Registry (CFFPR), eligible for their first evaluation for lung transplantation during the years 2001-2008 based on FEV1<30% predicted in two consecutive years.
Results: Within the CFFPR, 1240 patients met eligibility criteria. Eight hundred and nine (65.2%) were referred for lung transplant evaluation, and 431 (34.8%) were not referred. In a multivariable model, Medicaid insurance (OR 1.79, 95% CI 1.29-2.47), older age (per 5year increase; OR 1.25, 95% CI 1.13-1.39), lack of high school graduate education (OR 2.27, 95% CI 1.42-3.64), and Burkholderia cepacia complex sputum culture positivity (OR 2.48, 95% CI 1.50-4.12) were associated with non-referral, while number of pulmonary exacerbations (OR 0.93, 95% CI 0.87-0.99) and supplemental oxygen use (OR 0.59, 95% CI 0.43-0.81) were associated with increased referral.
Conclusions: Despite meeting lung function criteria for lung transplant evaluation, 35% of patients with CF had not yet been referred to a lung transplant center. Predictors of non-referral included markers of low socioeconomic status, older age and B. cepacia complex sputum culture. Further work is needed to understand the outcomes for non-referred patients in order to refine referral recommendations in this population.
Keywords: Cystic fibrosis; Lung transplantation; Referral.
Copyright © 2015 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Conflict of interest: The authors have no financial conflicts of interest
Figures




Comment in
-
Referral to lung transplantation--too little, too late.J Cyst Fibros. 2016 Mar;15(2):143-4. doi: 10.1016/S1569-1993(16)00020-5. J Cyst Fibros. 2016. PMID: 27062884 No abstract available.
References
-
- Cystic Fibrosis Foundation Patient Registry, 2012 Annual Data Report. Bethesda, Maryland: 2013.
-
- O’Sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009;373:1891–1904. - PubMed
-
- Yusen RD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Dobbels F, Goldfarb SB, Levvey BJ, Lund LH, Meiser B, Stehlik J. The Registry of the International Society for Heart and Lung Transplantation: Thirty-first Adult Lung and Heart-Lung Transplant Report-2014; Focus Theme: Retransplantation. The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation. 2014;33:1009–1024. - PubMed
-
- Orens JB, Estenne M, Arcasoy S, Conte JV, Corris P, Egan JJ, Egan T, Keshavjee S, Knoop C, Kotloff R, Martinez FJ, Nathan S, Palmer S, Patterson A, Singer L, Snell G, Studer S, Vachiery JL, Glanville AR. International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation. 2006;25:745–755. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous